Search

everythinglearnresearchcommunity

for

Search:↓

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

The elderly woman experienced hair loss and scalp itching, especially at the front hairline, and lost her eyebrows.

Different women have various natural hairline shapes, and understanding this is important for designing hair transplants.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Chinese scalps have fewer hair clusters than Caucasians, and transplanting 30 clusters per square centimeter creates a natural-looking hairline for bald Chinese individuals.

AGA more common in men, Koreans have lower rates and unique patterns.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

A boy had unusual synchronized hair growth with short active growth phases, not fitting known hair disorders.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Splitting single-hair grafts seems to improve perceived hair fullness without affecting growth, intact grafts grow slightly better, and the Mantis microscope is clear but slower without reducing damage to grafts.

Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Two young siblings experienced hair loss without hormone issues or other skin problems.

Men can experience female pattern hair loss, needing different treatments.

Hair transplants are effective for some women and many male-to-female transgender patients if done carefully by an experienced team.

Higher epinephrine concentration and specific injection sites increase scalp vasoconstriction time.

A treatment combining laser energy and injections improved hair loss and unexpectedly also reduced hair graying.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

Southeast and East Asian men typically have straighter hairlines with less recession and lower hair density, which is important to consider in hair restoration surgery.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Hyaluronic acid successfully treated skin atrophy caused by corticosteroid injections.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.